Diffuse large B cell lymphoma: using pathologic and molecular biomarkers to define subgroups for novel therapy

Diffuse large B cell lymphoma (DLBCL) comprises specific subtypes, disease entities, and other not otherwise specified (NOS) lymphomas. This review will focus on DLBCL NOS because of their prevalence and their heterogeneity with respect to morphology, clinical presentation, biology, and response to...

Descripción completa

Detalles Bibliográficos
Autores principales: Carbone, Antonino, Gloghini, Annunziata, Kwong, Yok-Lam, Younes, Anas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082139/
https://www.ncbi.nlm.nih.gov/pubmed/24870942
http://dx.doi.org/10.1007/s00277-014-2116-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082139/
https://www.ncbi.nlm.nih.gov/pubmed/24870942
http://dx.doi.org/10.1007/s00277-014-2116-y

Ejemplares similares